Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucosamine

T S Barclay1, C Tsourounis, G M McCart

  • 1School of Pharmacy, University of California, San Francisco 94143, USA.

The Annals of Pharmacotherapy
|June 2, 1998
PubMed
Summary
This summary is machine-generated.

Glucosamine may improve osteoarthritis symptoms, but research quality is low. Further studies are needed to confirm its efficacy and safety for osteoarthritis treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why change is needed in research examining dietary supplements.

Clinical pharmacology and therapeutics·2010
Same author

Effects of uptake and efflux transporter inhibition on erythromycin breath test results.

Clinical pharmacology and therapeutics·2007
Same author

Dietary supplement survey of pharmacists: personal and professional practices.

Journal of alternative and complementary medicine (New York, N.Y.)·2002
Same author

Clinical effects of phytoestrogens.

Clinical obstetrics and gynecology·2001
Same author

A survey of dietary supplement use during pregnancy at an academic medical center.

American journal of obstetrics and gynecology·2001
Same author

Implanon: a critical review.

The Annals of pharmacotherapy·2001
Same journal

Stability of Ceftazidime-Avibactam: Changes in Regulatory Information and Implications for Preparation.

The Annals of pharmacotherapy·2026
Same journal

Impact of Early Dose Adjustment of Piperacillin/Tazobactam on Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Multicenter Cohort Study.

The Annals of pharmacotherapy·2026
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
Same journal

Severe Acute Hepatitis Induced by Combined Rosuvastatin and Ticagrelor Therapy Post-PCI: The Challenges of Multi-Drug DILI Diagnosis.

The Annals of pharmacotherapy·2026
See all related articles

Area of Science:

  • Pharmacology and pharmacokinetics of glucosamine.
  • Osteoarthritis treatment modalities.

Background:

  • Osteoarthritis affects 12% of the US population, increasing with age.
  • Current treatments do not slow osteoarthritis progression.
  • Glucosamine is a popular, investigated treatment for osteoarthritis.

Purpose of the Study:

  • Review glucosamine pharmacology and pharmacokinetics.
  • Critically evaluate literature on glucosamine's safety and efficacy for osteoarthritis.

Main Methods:

  • Conducted a MEDLINE search (1965-1997) for osteoarthritis and glucosamine.
  • Reviewed cited references for additional literature.
  • Excluded studies lacking randomization, control groups, sufficient participants, or clear data.

Related Experiment Videos

Main Results:

  • Glucosamine is incorporated into articular cartilage after oral administration.
  • Three critically evaluated studies showed symptom improvement in the glucosamine group.
  • Study design flaws limit the clinical applicability of these findings.
  • Short-term adverse effects included mild gastrointestinal issues, drowsiness, and skin reactions.

Conclusions:

  • Clinical trials show symptom improvement with glucosamine for osteoarthritis.
  • Significant flaws in study design and data analysis exist.
  • More rigorous research is required before recommending glucosamine for osteoarthritis.